Conference Call Presents Exciting Opportunities and Milestone Events Expected from Imaging3 in 2007.

Imaging3 CEO Discusses Excellent New Opportunities as Well as Plans for Beta Testing, FDA Application, and Production of the Patented 3D, Real-Time Dominion Technology

BURBANK, Calif. -- Imaging3[TM], Inc., (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company held a successful, interactive conference call held for investors and press on Tuesday, February 6, 2007.

Led by Imaging3 CEO, Mr. Dean Janes, the conference call reviewed key events of last year and laid out the excellent opportunities ahead. Mr. Janes discussed the notable achievements from last year, including the well-received unveiling of the Dominion at the 2006 RSNA annual meeting in Chicago. Given the spate of accomplishments in 2006, the New Year is projected to be a time of lucrative growth and change. Looking forward, 2007 strategy anticipates expansion of the company's established C-arm business, beta testing of the Dominion at university hospitals in first quarter, FDA application in second quarter, and production to begin in late 2007 moving into 2008.

Mr. Janes' presentation was followed by a comprehensive question and answer session covering a wide-range of topics related to Imaging3 technology and products, including global marketing plans, luminary sites, evolving technology, and projected timelines.

Following the call, Mr. Janes purveyed his confidence in the coming year by stating, "The conference call communicated to the immense excitement and forward momentum at Imaging3. Investors, physicians, and distributors alike are on board and eagerly anticipating the effect the entrance of Imaging3 technology could have on the medical world."

The February 6 conference call is now available on audio Webcast. To tune in, click on the following Imaging3 Conference Call link or visit http://www.imaging3.com.

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at http://www.imaging3.com for more information

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive, and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.